Security readout for executives and security teams
Plain-English summary
This affects certain BD Kiestra and BD InoqulA laboratory automation systems. A privileged authorized user can issue SQL commands through affected DB Manager or PerformA versions, which could corrupt operational or clinical workflow data. The source bundle does not provide a CVSS score or confirmed exploitation evidence.
Executive priority
Treat as a targeted operational integrity risk for affected laboratories, not a broad internet-scale emergency based on the provided evidence. Prioritize inventory, vendor guidance review, and privileged access control.
Technical view
CVE-2018-10593 covers BD Kiestra TLA, BD Kiestra WCA, and BD InoqulA+ systems using DB Manager 3.0.1.0 and earlier or PerformA 3.0.0.0 and earlier. The issue allows a privileged authenticated user to issue SQL commands, potentially causing data corruption.
Likely exposure
Exposure appears limited to organizations operating the named BD laboratory automation systems with the affected DB Manager or PerformA versions and privileged user access paths.
Exploitation context
The provided bundle does not show CISA KEV listing, active exploitation, public exploit availability, or unauthenticated access. The risk is insider, compromised privileged account, or misuse by authorized administrators.
Researcher notes
Evidence is limited to the CVE description and referenced BD/CISA advisories. No CVSS vector, patch detail, or exploitation status is included in the provided bundle, so conclusions should stay bounded to authenticated privileged SQL command capability and possible data corruption.
Mitigation direction
- Inventory BD Kiestra and BD InoqulA systems and record DB Manager and PerformA versions.
- Check BD and CISA advisory guidance for vendor-approved fixes or compensating controls.
- Restrict privileged account access to personnel with a documented operational need.
- Monitor database integrity and operational logs for unauthorized or unexpected SQL activity.
Validation and detection
- Confirm whether systems are BD Kiestra TLA, BD Kiestra WCA, or BD InoqulA+.
- Verify installed DB Manager and PerformA versions against the affected version ranges.
- Review privileged account assignments and recent administrative activity.
- Document whether vendor guidance has been reviewed and applied.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CWE-356: Exact CWE lookup
Use the exact CWE identifier as the starting point before reviewing related ATT&CK behavior. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.
Open ATT&CK lookupCVE-2018-10593 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Unknown
- CVSS
- Not scored
- Known Exploited
- No
- Published
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
CVSS and timeline data
No CVSS vectors or timeline events were available in the normalized CVE source material.
Source materials
- CVE List V5 sourceCVE List V5
- https://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-bd-kiestra-tla-bd-kiestra-wca-bd-inoqulaCVE reference · x_refsource_CONFIRM
- https://ics-cert.us-cert.gov/advisories/ICSMA-18-142-01CVE reference · x_refsource_MISC
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.
Product UI does not Warn User of Unsafe Actions
Product UI does not Warn User of Unsafe Actions represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.